English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17938/22955 (78%)
Visitors : 7404177      Online Users : 102
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/18991


    Title: Hyaluronic acid-based nano-sized drug carrier-containing Gellan gum microspheres as potential multifunctional embolic agent
    Authors: Hsu, Ming Fang;Tyan, Yen Sheng;Chien, Yu Chen;Lee, Ming Wei
    Contributors: 中山醫學大學
    Date: 2018-12-01
    Issue Date: 2018-03-21T09:50:36Z (UTC)
    Publisher: Nature Publishing Group
    ISSN: 20452322
    Abstract: The purpose of this study was to develop a gellan gum-based multifunctional embolic agent. Calibrated spherical gellan gum and nanoparticle-containing gellan gum microspheres were prepared via water-in oil emulsification method. Self-assembled nanoparticles composed of short-chain hyaluronic acid and polyethylenimine as the doxorubicin carrier were prepared. The short-chain hyaluronic acid/polyethylenimine/ doxorubicin (sHH/PH/Dox) with the mean size was 140 ± 8 nm. To examine sHH/PH/Dox nanoparticle uptake into cells, the results confirmed that sHH/PH nanoparticles as drug carrier can facilitate the transport of doxorubicin into HepG2 liver cancer cells. Subsequently, sHH/PH/Dox merged into the gellan gum (GG) microspheres forming GG/sHH/PH/Dox microsphere. After a drug release experiment lasting 45 days, the amount of released doxorubicin from 285, 388, and 481 μm GG/sHH/PH/Dox microspheres were approximately 4.8, 1.8 and 1.1-fold above the IC50 value of the HepG2 cell. GG/sHH/PH/Dox microspheres were performed in rabbit ear embolization model and ischemic necrosis on ear was visible due to the vascular after 8 days. Regarding the application of this device in the future, we aim to provide better embolization agents for transcatheter arterial chemoembolization (TACE). © 2018 The Author(s).
    URI: https://www.doi.org/10.1038/s41598-018-19191-7
    https://ir.csmu.edu.tw:8080/ir/handle/310902500/18991
    Relation: Scientific Reportsvolume 8, Article number: 731 (2018)
    Appears in Collections:[醫學檢驗暨生物技術學系暨碩士班] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML362View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback